Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-894 in Diabetic Neuropathic Pain
NCT00507936Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Countries
- 7
01
Overview
A Phase 2 trial of sofinicline in diabetic polyneuropathy (DPN), sponsored by AbbVie Inc.. Started Aug 2007; status: completed.
02
Drugs
sofinicline
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NCT00507936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507936.